Compassionate Use of Dupilumab

NCT04776694 · clinicaltrials.gov ↗

APPROVED_FOR_MARKETING

Status

INDUSTRY

Sponsor class

Conditions

Type 2 Inflammatory Disorders

Interventions

DRUG: Dupilumab

Sponsor

Regeneron Pharmaceuticals